CAREY D CRILL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health BOISE, ID NPI 1457530693
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health ID Axsome Therapeutics, Inc. All categories
General Payments — all program years on this page
$18,672.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 293
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,418.50 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,463.00 | 1 |
| Food and Beverage | $1,093.09 | 42 |
| Compensation for serving as faculty or as a speaker for a medical education program | $975.00 | 1 |
| Travel and Lodging | $887.41 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Axsome Therapeutics, Inc. | $2,555.80 | 3 |
| Janssen Pharmaceuticals, Inc | $1,081.68 | 7 |
| Supernus Pharmaceuticals, Inc. | $142.74 | 3 |
| Otsuka America Pharmaceutical, Inc. | $105.94 | 5 |
| Teva Pharmaceuticals USA, Inc. | $88.98 | 4 |
| ABBVIE INC. | $82.80 | 5 |
| Neurocrine BioSciences, Inc. | $68.52 | 2 |
| ITI, Inc. | $57.60 | 3 |
| Alkermes, Inc. | $55.87 | 3 |
| Corium, Inc. | $37.49 | 4 |
| IRONSHORE PHARMACEUTICALS INC. | $34.73 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $31.05 | 2 |
| Tris Pharma Inc | $23.94 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $19.48 | 1 |
| Lundbeck LLC | $17.82 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.06 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.